Tag: CompleTest™

February 13, 2019

FluroTech Engages CFN Media and Becomes DTC Eligible

FluroTech (TSXV:TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to announce that it has retained the services of CFN Media (“CFN”)...
February 11, 2019

FluroTech Wins Best of Show for New Technology by High! Canada Magazine at the Vancouver Lift Expo

FluroTech (TSXV:TEST)  (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to announce that the CompleTest™ was selected as the best of...
February 5, 2019

FluroTech Announces Product Certification and Commencement of Sales

FluroTech (TSXV:TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to announce that both the desktop and portable CompleTest™ devices, along with...
January 7, 2019

Flurotech Announces OTCQB Listing

FluroTech Ltd. (TSXV:TEST) (OTCQB:FLURF), (“FluroTech” or the “Company”), is pleased to announce that its common shares commenced trading today on the...
November 21, 2018

FluroTech Submits Letter of Intention to the Drugs and Driving Committee

FluroTech (TSXV:TEST), ("FluroTech" or the "Company"), is pleased to announce it has submitted its letter of intention to submit saliva-based roadside drug...
November 5, 2018

FluroTech Protects Its Technological Advantage with Patent Application

FluroTech (TSXV:TEST), ("FluroTech" or the "Company"), is pleased to announce two recently-filed patent applications to which the Company holds exclusive, irrevocable...
October 23, 2018

FluroTech Designs a Cocaine Test for Roadside Impairment Testing

FluroTech (TSXV:TEST), ("FluroTech" or the "Company"), a developer of a human saliva-based testing device designed to accurately measure concentrations of ∆9-tetrahydrocannabinol ("THC"), methamphetamines and cocaine, is pleased...